{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04930991",
            "orgStudyIdInfo": {
                "id": "OU-SCC-Omeprazole"
            },
            "organization": {
                "fullName": "University of Oklahoma",
                "class": "OTHER"
            },
            "briefTitle": "High Dose Omeprazole in Patients With Pancreatic Cancer",
            "officialTitle": "A Phase 0 Study of High Dose Omeprazole in Patients With Pancreatic Cancer Planning to Undergo Surgical Therapy for Evaluating Changes of Biomarkers",
            "acronym": "OU202005AJ",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "high-dose-omeprazole-in-patients-with-pancreatic-cancer"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-02",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-09-07",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-06",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-06",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-03-29",
            "studyFirstSubmitQcDate": "2021-06-10",
            "studyFirstPostDateStruct": {
                "date": "2021-06-18",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-02-13",
            "lastUpdatePostDateStruct": {
                "date": "2024-02-15",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "University of Oklahoma",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to test the safety of high dose omeprazole and see what effects that it has on patients with exocrine pancreatic cancer.",
            "detailedDescription": "During this study patients will receive treatment of omeprazole at the dose depending on group enrollment\n\n* Group A will receive omeprazole 80 mg, twice a day for 14 days unless unacceptable toxicity\n* Group B, will receive omeprazole 20 mg, once a day for 14 days\n\nPatients will receive treatment for 2\\~3 weeks during the study, and 2 months of follow up.\n\nTotal accrual is anticipated to take 2 years."
        },
        "conditionsModule": {
            "conditions": [
                "Exocrine Pancreatic Cancer"
            ],
            "keywords": [
                "pancreatic cancer",
                "omeprazole"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "EARLY_PHASE1"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 60,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Arm A (High Dose)",
                    "type": "EXPERIMENTAL",
                    "description": "Omeprazole, 80 mg, PO, BID for 2 weeks prior to surgical therapy of pancreatectomy. All 30 subjects in Arm A to be enrolled prior to Arm B cohort enrollment.",
                    "interventionNames": [
                        "Drug: Omeprazole"
                    ]
                },
                {
                    "label": "Arm B (Normal Dose)",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Omeprazole, 20 mg, PO, QD for 2 weeks prior to surgical therapy of pancreatectomy.",
                    "interventionNames": [
                        "Drug: Omeprazole"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Omeprazole",
                    "description": "Treatment will consist of Omeprazole 2 weeks prior to surgical therapy of pancreatectomy.",
                    "armGroupLabels": [
                        "Arm A (High Dose)",
                        "Arm B (Normal Dose)"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Proportion",
                    "description": "Proportion of subjects receiving study treatment without adverse events that would significantly delay the surgery",
                    "timeFrame": "2 years"
                },
                {
                    "measure": "Safety and Tolerability",
                    "description": "Frequency and severity of treatment related adverse events per CTCAE v5",
                    "timeFrame": "2 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "v-ATPase LC3-I and LC3-II expression",
                    "description": "v-ATPase LC3-I and LC3-II expression on pancreatic tumor",
                    "timeFrame": "2 years"
                },
                {
                    "measure": "pH",
                    "description": "pH of tumor tissue",
                    "timeFrame": "2 years"
                },
                {
                    "measure": "Correlation",
                    "description": "Correlation of biomarker changes with potential cancer cell apoptosis",
                    "timeFrame": "2 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Newly diagnosed exocrine pancreatic cancer with pathology confirmed as adenocarcinoma\n* Patient is a candidate for surgical resection of pancreatic cancer\n* \u2265 18 years old at the time of informed consent\n* ECOG Performance Status 0-2\n* Patients with or without neoadjuvant chemotherapy will be eligible\n* Ability to provide written informed consent and HIPAA authorization\n* Women of childbearing potential definition must have a negative pregnancy test within 14 days of registration. All women (regardless of sexual orientation, having undergone a tubal ligation, or remaining celibate by choice) are considered to have childbearing potential unless they meet one of the following criteria:\n* Prior hysterectomy or bilateral oophorectomy;\n* Has not had menses at any time in the preceding 24 consecutive months\n* Adequate organ function for surgical therapy\n\nExclusion Criteria:\n\n* Patients with pancreatic malignant tumor histologically confirmed as neuroendocrine or any other type of malignancies\n* Positive pregnancy test, pregnant, or breastfeeding\n* Known hypersensitivity to any component of the formulation or substituted benzimidazoles\n* Any other clinically significant laboratory abnormality that would compromise patient safety or the outcome of the study\n* Any clinically significant and/or uncontrolled cardiac-related abnormality that would compromise patient safety or the outcome of the study\n* Medical condition that might affect the absorption of study medications in the opinion of the investigator.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "99 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "SCC IIT Office",
                    "role": "CONTACT",
                    "phone": "405-271-8777",
                    "email": "SCC-IIT-Office@ouhsc.edu"
                },
                {
                    "name": "Ingrid Block",
                    "role": "CONTACT",
                    "phone": "405-271-8777"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Ajay Jain, MD",
                    "affiliation": "University of Oklahoma",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Stephenson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Oklahoma City",
                    "state": "Oklahoma",
                    "zip": "73104",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "SCC IIT Office",
                            "role": "CONTACT",
                            "phone": "405-271-8777",
                            "email": "SCC-IIT-Office@ouhsc.edu"
                        },
                        {
                            "name": "Ajay Jain, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.46756,
                        "lon": -97.51643
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000010190",
                    "term": "Pancreatic Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000004067",
                    "term": "Digestive System Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000004701",
                    "term": "Endocrine Gland Neoplasms"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                },
                {
                    "id": "D000010182",
                    "term": "Pancreatic Diseases"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M13110",
                    "name": "Pancreatic Neoplasms",
                    "asFound": "Pancreatic Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7256",
                    "name": "Digestive System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8886",
                    "name": "Gastrointestinal Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7863",
                    "name": "Endocrine Gland Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M13102",
                    "name": "Pancreatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T4387",
                    "name": "Pancreatic Cancer",
                    "asFound": "Pancreatic Cancer",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009853",
                    "term": "Omeprazole"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000897",
                    "term": "Anti-Ulcer Agents"
                },
                {
                    "id": "D000005765",
                    "term": "Gastrointestinal Agents"
                },
                {
                    "id": "D000054328",
                    "term": "Proton Pump Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12785",
                    "name": "Omeprazole",
                    "asFound": "2 days",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4188",
                    "name": "Antacids",
                    "relevance": "LOW"
                },
                {
                    "id": "M4219",
                    "name": "Anti-Ulcer Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M8881",
                    "name": "Gastrointestinal Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M27630",
                    "name": "Proton Pump Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Gast",
                    "name": "Gastrointestinal Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}